SEC Form 4 · accession 0001493152-16-015977
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Punit Dhillon
Officer — President and CEO · Director
Period of report
Dec 14, 2016
Accepted (ET)
Dec 16, 2016 · 5:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F3,F2 | $4.20 | Dec 14, 2016 | D | 25,000 | D | — | Apr 25, 2022 | Common Stock | 25,000 | 0 | D |
| Employee Stock Option (right to buy)F1,F3,F4 | $4.60 | Dec 14, 2016 | D | 12,500 | D | — | Feb 8, 2023 | Common Stock | 12,500 | 0 | D |
| Non-qualified Stock Option (right to buy)F5,F3,F6 | $16.10 | Dec 14, 2016 | D | 100,000 | D | — | Mar 7, 2024 | Common Stock | 100,000 | 0 | D |
| Employee Stock Option (right to buy)F1,F3,F7 | $7.60 | Dec 14, 2016 | D | 25,000 | D | — | Mar 3, 2025 | Common Stock | 25,000 | 0 | D |
| Employee Stock Option (right to buy)F1,F3,F8 | $5.76 | Dec 14, 2016 | D | 500,000 | D | — | Aug 21, 2025 | Common Stock | 500,000 | 0 | D |
| Employee Stock Option (right to buy)F1,F3,F9 | $1.29 | Dec 14, 2016 | A | 314,583 | A | — | Dec 14, 2026 | Common Stock | 314,583 | 314,583 | D |
Explanation of responses
- F1These stock options were granted as Incentive Stock Options only to the extent that the $100,000 dollar limitation of 26 U.S.C. ss.422(d) is not exceeded; anything beyond that is deemed a Non-qualified Stock Option.
- F2The stock options were scheduled to fully vest on April 25, 2015, the third anniversary of the grant date.
- F3On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its Stock Option Exchange Program, options previously granted to and held by the reporting person to purchase 25000 shares (previously granted on April 25, 2012), 12500 shares (previously granted on February 8, 2013), 100000 shares (previously granted on March 7, 2014), 25000 shares (previously granted on March 3, 2015), and 500000 shares (previously granted on August 21, 2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 314583 shares of common stock with an exercise price of $1.29 per share.
- F4The stock options were scheduled to fully vest on February 8, 2016, the third anniversary of the grant date.
- F5These stock options were granted as Non-qualified stock options.
- F6The stock options were scheduled to fully vest on March 7, 2017, the third anniversary of the grant date.
- F7The stock options were scheduled to fully vest on March 3, 2018, the third anniversary of the grant date.
- F8The stock options were scheduled to fully vest on August 21, 2018, the third anniversary of the grant date.
- F9The stock options granted on December 14, 2016 will vest on the following schedule: 25% vested on the grant date; 1/36th of the remaining 75% will vest on each of the 36 subsequent monthly anniversaries of the grant date.